CEO Jonathan Klamkin sold 20,000 shares (89.3% of holdings) across 5 separate sales for $500,660.78 under 10b5-1 plan
Jonathan Klamkin, Chief Executive Officer, executed 5 separate sales on 2026-06-01 totaling 20,000 shares for $500,660.78 at prices ranging from $22.19 to $26.25, reducing his holdings from 22,403 to 2,403 shares (an 89.3% reduction). This transaction was part of a pre-arranged 10b5-1 trading plan adopted on 2025-12-03, meaning it was scheduled and not discretionary. Aeluma is operating at a significant loss with a net income of $-1,800,000 ($-1.8M) on quarterly revenue of $1,222,000 ($1.2M), despite strong annual revenue growth of +407.9%, and the CEO's near-complete exit of his position warrants investor attention given the company's unprofitable state and the magnitude of the stake reduction.